A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin’s lymphoma

被引：0
|
作者：
Sun Jin Sym
Dae Ho Lee
Hye Jin Kang
Seung Hyun Nam
Ho Young Kim
Seok Jin Kim
Hyeon Seok Eom
Won Seog Kim
Cheolwon Suh
机构：
[1] Asan Medical Center,Department of Internal Medicine
[2] University of Ulsan College of Medicine,Department of Medicine
[3] Korea Institute of Radiological and Medical Sciences,Department of Internal Medicine
[4] Seoul Veterans Hospital,Department of Internal Medicine, Sacred Heart Hospital
[5] College of Medicine,Department of Internal Medicine
[6] Hallym University,Hematology–Oncology Clinic, Research Institute and Hospital
[7] College of Medicine,Department of Medicine, Samsung Medical Center
[8] Korea University,Department of Internal Medicine
[9] National Cancer Center,undefined
[10] School of Medicine,undefined
[11] Sungkyunkwan University,undefined
[12] Gachon University Gil Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2009年 / 64卷
关键词：
Oxaliplatin; Lymphoma; Salvage therapy; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：27 / 33
页数：6
相关论文
共 50 条
  • [21] Phase II trial for lenalidomide alone in relapsed/refractory aggressive non-Hodgkin lymphoma
    不详
    CLINICAL LYMPHOMA & MYELOMA, 2007, 7 (05): : 339 - 339
  • [22] A phase II trial of gemcitabine, ifosfamide, dexamethasone, and oxaliplatin (GIDOX) for patients with refractory or relapsed non-Hodgkin's lymphoma
    Park, B.
    Kim, W.
    Eom, H.
    Kim, J.
    Oh, S.
    Suh, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [23] A PHASE II TRIAL OF GEMCITABINE, IFOSFAMIDE, DEXAMATHASONE, AND OXALIPLATIN (GIDOX) FOR PATIENTS WITH REFRACTORY OR RELAPSED NON-HODGKIN'S LYMPHOMA
    Park, B. B.
    Kim, W. S.
    Eom, H. S.
    Kim, J. S.
    Oh, S. J.
    Hwang, I. G.
    Suh, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 652 - 652
  • [24] A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma
    Srivastava, Shivani
    Jones, David
    Wood, Lisa L.
    Schwartz, Jennifer E.
    Nelson, Robert P., Jr.
    Abonour, Rafat
    Secrest, Angie
    Cox, Elizabeth
    Baute, Jay
    Sullivan, Cheryl
    Kane, Kathleen
    Robertson, Michael.
    Farag, Sherif S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (07) : 987 - 994
  • [25] Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma
    Ribrag, Vincent
    Caballero, Dolores
    Ferme, Christophe
    Zucca, Emanuele
    Arranz, Reyes
    Briones, Javier
    Gisselbrecht, Christian
    Salles, Gilles
    Gianni, Alessandro M.
    Gomez, Henry
    Kahatt, Carmen
    Corrado, Claudia
    Szyldergemajn, Sergio
    Extremera, Sonia
    de Miguel, Bernardo
    Cullell-Young, Martin
    Cavalli, Franco
    HAEMATOLOGICA, 2013, 98 (03) : 357 - 363
  • [26] Cologne high-dose sequential chemotherapy in relapsed and refractory aggressive non-Hodgkin lymphoma - results of a multicentre Phase II study
    Josting, A
    Sieniawski, M
    Staak, JO
    Glossmann, JP
    Diehl, V
    Engert, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S245 - S245
  • [27] Biweekly dose-dense gemcitabine-oxaliplatin and dexamethasone for relapsed/refractory aggressive non-Hodgkin lymphoma: A multicenter, single-arm, phase II trial
    Jo, Jae-Cheol
    Baek, Jin Ho
    Lee, Je-Hwan
    Joo, Young-Don
    Bae, Sung-Hwa
    Lee, Jung-Lim
    Lee, Jung-Hee
    Kim, Dae-Young
    Lee, Won-Sik
    Ryoo, Hun Mo
    Choi, Yunsuk
    Kim, Hawk
    Lee, Kyoo-Hyung
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2016, 12 (02) : 159 - 166
  • [28] High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma:: results of a multicenter phase II study
    Josting, A
    Sieniawski, M
    Glossmann, JP
    Staak, O
    Nogova, L
    Peters, N
    Mapara, M
    Dörken, B
    Ko, Y
    Metzner, B
    Kisro, J
    Diehl, V
    Engertl, A
    ANNALS OF ONCOLOGY, 2005, 16 (08) : 1359 - 1365
  • [29] High-dose cytarabine and mitoxantrone as salvage therapy for refractory non-Hodgkin's lymphoma
    Wang, WS
    Tzeng, CH
    Chiou, TJ
    Liu, JH
    Hsieh, RK
    Yen, CC
    Chen, PM
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1997, 27 (03) : 154 - 157
  • [30] A multicenter phase II study of darinaparsin in relapsed or refractory Hodgkin's and non-Hodgkin's lymphoma
    Hosein, Peter J.
    Craig, Michael D.
    Tallman, Martin S.
    Boccia, Ralph V.
    Hamilton, Brian L.
    Lewis, Jonathan J.
    Lossos, Izidore S.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (01) : 111 - 114
12345